Malaria drug ‘may slow pancreatic cancer growth’
March 16th, 2011 - 1:06 pm ICT by ANIWashington, Mar 16 (ANI): Scientists say they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.
The pre-clinical results have already prompted the opening of a small clinical trial in patients with advanced pancreatic cancer, one of the deadliest and hardest-to-treat forms of cancer, said the investigators, led by Alec Kimmelman, a radiation oncologist at Dana-Farber Cancer Institute.
“We are seeing robust and impressive responses in pancreatic cancer mouse models,” said Kimmelman, whose laboratory specializes in studies of pancreatic cancer, the fourth-leading cause of cancer death in the United States. The oral drug, hydroxychloroquine, is inexpensive, widely available, and causes relatively mild side effects, he said. A second, planned clinical trial will combine the drug with radiation.
“While these findings are indeed exciting and a cause for optimism, one needs to be mindful that so far the effects, while impressive, have only been shown in mice,” said Ronald DePinho, MD, director of the Belfer Institute for Applied Cancer Science at Dana-Farber. “I eagerly await to see how the human studies will progress.”
The pre-clinical results will appear in the April issue of the journal Genes & Development and is currently published on its web site. (ANI)
- Molecular predictor of metastatic prostate cancer identified - Feb 03, 2011
- New strategy to fight cancer drug resistance discovered - Jun 21, 2010
- Scientists unlock secret of eternal youth - Nov 29, 2010
- 'Smart' lung cancer drug shows promise - Oct 28, 2010
- India witnessing rise in pancreatic cancer, say doctors - Oct 06, 2011
- First molecule that blocks key component of cancer genes' on-off switch created - Sep 25, 2010
- US cancer death rates continue to decline - Mar 29, 2012
- New drug shows promise against platinum resistant ovarian cancer - Oct 10, 2010
- Dying at home 'better for cancer patients' - Sep 16, 2010
- New research paves way for better Graves' disease treatment - Dec 02, 2010
- How melanoma tumours evade drug treatment - Nov 25, 2010
- Scientists may have found 'elixir of eternal youth' - Nov 29, 2010
- Super vaccine could knock out 70 percent of cancers - Dec 13, 2011
- Popular diabetes drug may help fight breast cancer - Sep 15, 2009
- Gene mutations help leukemia drug fight squamous cell lung cancer - Apr 04, 2011
Tags: belfer institute, cancer death, cancer growth, cancer science, cause of cancer, clinical trial, dana farber cancer, dana farber cancer institute, farber cancer institute, hydroxychloroquine, kimmelman, malaria drug, md director, mild side, mouse models, oral drug, pancreatic cancer, pancreatic tumors, radiation oncologist, rheumatoid arthritis